nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Methotrexate—bone cancer	0.847	1	CbGbCtD
Gadopentetate dimeglumine—Pain in extremity—Epirubicin—bone cancer	0.000395	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Epirubicin—bone cancer	0.000395	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Cisplatin—bone cancer	0.000393	0.00257	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000392	0.00256	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Epirubicin—bone cancer	0.000389	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Doxorubicin—bone cancer	0.000384	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Epirubicin—bone cancer	0.000382	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00038	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Cisplatin—bone cancer	0.000378	0.00247	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000378	0.00247	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Epirubicin—bone cancer	0.000376	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Cisplatin—bone cancer	0.000371	0.00243	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Epirubicin—bone cancer	0.00037	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Cisplatin—bone cancer	0.000369	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Cisplatin—bone cancer	0.000368	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Doxorubicin—bone cancer	0.000366	0.00239	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Doxorubicin—bone cancer	0.000366	0.00239	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Cisplatin—bone cancer	0.000366	0.00239	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Epirubicin—bone cancer	0.000361	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Cisplatin—bone cancer	0.000361	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Doxorubicin—bone cancer	0.00036	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000356	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Cisplatin—bone cancer	0.000354	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Epirubicin—bone cancer	0.000354	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Doxorubicin—bone cancer	0.000353	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Methotrexate—bone cancer	0.00035	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Doxorubicin—bone cancer	0.000348	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000345	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Doxorubicin—bone cancer	0.000343	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Cisplatin—bone cancer	0.00034	0.00222	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Cisplatin—bone cancer	0.000337	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Doxorubicin—bone cancer	0.000334	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Epirubicin—bone cancer	0.000333	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000329	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Cisplatin—bone cancer	0.000329	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Doxorubicin—bone cancer	0.000327	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000327	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Methotrexate—bone cancer	0.000326	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Pain—Cisplatin—bone cancer	0.000324	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Methotrexate—bone cancer	0.00032	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Methotrexate—bone cancer	0.000316	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Epirubicin—bone cancer	0.000316	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Methotrexate—bone cancer	0.000312	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Cisplatin—bone cancer	0.000312	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Doxorubicin—bone cancer	0.000308	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Methotrexate—bone cancer	0.000308	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Epirubicin—bone cancer	0.000305	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Epirubicin—bone cancer	0.000299	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Cisplatin—bone cancer	0.000299	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Epirubicin—bone cancer	0.000296	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Epirubicin—bone cancer	0.000292	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Doxorubicin—bone cancer	0.000292	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Methotrexate—bone cancer	0.000289	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Epirubicin—bone cancer	0.000288	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Methotrexate—bone cancer	0.000286	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Doxorubicin—bone cancer	0.000282	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Methotrexate—bone cancer	0.000282	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Cisplatin—bone cancer	0.000279	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Epirubicin—bone cancer	0.000278	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—bone cancer	0.000277	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Methotrexate—bone cancer	0.000276	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—bone cancer	0.000274	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—bone cancer	0.000274	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Methotrexate—bone cancer	0.000273	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Methotrexate—bone cancer	0.000272	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Cisplatin—bone cancer	0.000271	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Methotrexate—bone cancer	0.000271	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—bone cancer	0.00027	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—bone cancer	0.00027	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—bone cancer	0.000269	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—bone cancer	0.000269	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—bone cancer	0.000268	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000267	0.00174	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Methotrexate—bone cancer	0.000265	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Methotrexate—bone cancer	0.000264	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—bone cancer	0.000264	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Methotrexate—bone cancer	0.000263	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Chills—Methotrexate—bone cancer	0.000262	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Cisplatin—bone cancer	0.000259	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—bone cancer	0.000259	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—bone cancer	0.000258	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Methotrexate—bone cancer	0.000256	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—bone cancer	0.000256	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—bone cancer	0.000255	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Methotrexate—bone cancer	0.000254	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—bone cancer	0.000254	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—bone cancer	0.000254	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—bone cancer	0.000254	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—bone cancer	0.00025	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—bone cancer	0.000249	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Methotrexate—bone cancer	0.000249	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—bone cancer	0.000249	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—bone cancer	0.000248	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—bone cancer	0.000248	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—bone cancer	0.000247	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—bone cancer	0.000246	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Methotrexate—bone cancer	0.000246	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—bone cancer	0.000245	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—bone cancer	0.000244	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—bone cancer	0.000244	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Cisplatin—bone cancer	0.000241	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—bone cancer	0.00024	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—bone cancer	0.000239	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Rash—Cisplatin—bone cancer	0.000239	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Cisplatin—bone cancer	0.000238	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—bone cancer	0.000238	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—bone cancer	0.000236	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—bone cancer	0.000236	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—bone cancer	0.000235	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—bone cancer	0.000235	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—bone cancer	0.000234	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—bone cancer	0.000233	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Epirubicin—bone cancer	0.00023	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—bone cancer	0.00023	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methotrexate—bone cancer	0.000229	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—bone cancer	0.000229	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—bone cancer	0.000228	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—bone cancer	0.000227	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—bone cancer	0.000226	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Cisplatin—bone cancer	0.000225	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Cough—Methotrexate—bone cancer	0.000222	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—bone cancer	0.000222	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methotrexate—bone cancer	0.00022	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—bone cancer	0.00022	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—bone cancer	0.000219	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Methotrexate—bone cancer	0.000217	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Methotrexate—bone cancer	0.000217	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—bone cancer	0.000216	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—bone cancer	0.000216	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000215	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—bone cancer	0.000215	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—bone cancer	0.000214	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—bone cancer	0.000213	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Methotrexate—bone cancer	0.000209	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—bone cancer	0.000209	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Methotrexate—bone cancer	0.000208	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—bone cancer	0.000206	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—bone cancer	0.000206	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Methotrexate—bone cancer	0.000204	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—bone cancer	0.000203	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—bone cancer	0.000203	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—bone cancer	0.000202	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—bone cancer	0.000202	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methotrexate—bone cancer	0.000202	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000201	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Methotrexate—bone cancer	0.000201	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—bone cancer	0.000199	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—bone cancer	0.000198	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Methotrexate—bone cancer	0.000198	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—bone cancer	0.000198	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—bone cancer	0.000196	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—bone cancer	0.000194	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methotrexate—bone cancer	0.000194	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—bone cancer	0.000194	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—bone cancer	0.000192	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—bone cancer	0.000191	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—bone cancer	0.000191	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—bone cancer	0.000191	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—bone cancer	0.00019	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—bone cancer	0.00019	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000189	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—bone cancer	0.000189	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—bone cancer	0.000188	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—bone cancer	0.000188	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—bone cancer	0.000188	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—bone cancer	0.000187	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methotrexate—bone cancer	0.000186	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000186	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—bone cancer	0.000185	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Methotrexate—bone cancer	0.000185	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Methotrexate—bone cancer	0.000185	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—bone cancer	0.000183	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—bone cancer	0.000182	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—bone cancer	0.000181	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Methotrexate—bone cancer	0.00018	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—bone cancer	0.00018	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000179	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methotrexate—bone cancer	0.000179	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Pain—Methotrexate—bone cancer	0.000178	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000177	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—bone cancer	0.000177	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—bone cancer	0.000176	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—bone cancer	0.000175	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—bone cancer	0.000175	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—bone cancer	0.000174	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—bone cancer	0.000174	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—bone cancer	0.000173	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—bone cancer	0.000173	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—bone cancer	0.000171	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methotrexate—bone cancer	0.000171	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methotrexate—bone cancer	0.00017	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—bone cancer	0.000169	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—bone cancer	0.000168	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000168	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—bone cancer	0.000168	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—bone cancer	0.000166	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—bone cancer	0.000166	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Methotrexate—bone cancer	0.000165	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Methotrexate—bone cancer	0.000164	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methotrexate—bone cancer	0.000164	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000164	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—bone cancer	0.000161	0.00106	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—bone cancer	0.00016	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—bone cancer	0.00016	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—bone cancer	0.00016	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—bone cancer	0.000159	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—bone cancer	0.000156	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000155	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—bone cancer	0.000155	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—bone cancer	0.000154	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—bone cancer	0.000154	0.001	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—bone cancer	0.000154	0.001	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—bone cancer	0.000154	0.001	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—bone cancer	0.000154	0.001	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Methotrexate—bone cancer	0.000153	0.001	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Methotrexate—bone cancer	0.000149	0.000974	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—bone cancer	0.000148	0.000968	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000147	0.000961	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methotrexate—bone cancer	0.000147	0.00096	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—bone cancer	0.000143	0.000936	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—bone cancer	0.000143	0.000933	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—bone cancer	0.000142	0.000929	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—bone cancer	0.000142	0.000929	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methotrexate—bone cancer	0.000142	0.000928	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Epirubicin—bone cancer	0.000139	0.000911	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—bone cancer	0.000137	0.000898	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methotrexate—bone cancer	0.000137	0.000897	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—bone cancer	0.000133	0.000869	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—bone cancer	0.000132	0.000866	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methotrexate—bone cancer	0.000132	0.000863	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methotrexate—bone cancer	0.000131	0.000856	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methotrexate—bone cancer	0.000131	0.000855	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methotrexate—bone cancer	0.00013	0.00085	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—bone cancer	0.000129	0.000843	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Epirubicin—bone cancer	0.000128	0.00084	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—bone cancer	0.000127	0.000831	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—bone cancer	0.000124	0.000807	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methotrexate—bone cancer	0.000123	0.000806	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—bone cancer	0.000123	0.000804	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—bone cancer	0.000123	0.000801	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—bone cancer	0.000122	0.0008	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—bone cancer	0.000122	0.000796	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—bone cancer	0.000119	0.000777	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—bone cancer	0.000115	0.000754	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—bone cancer	0.000114	0.000747	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—bone cancer	0.000113	0.000741	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—bone cancer	0.000113	0.00074	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—bone cancer	0.000113	0.000736	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—bone cancer	0.000107	0.000698	CcSEcCtD
